Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa-Reference-Cited by-同舟云学术

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa

Published:2021-07-20 Issue:12 Volume:81 Page:1397-1410
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Aarts Pim^ORCID,Dudink Koen^ORCID,Vossen Allard R. J. V.^ORCID,van Straalen Kelsey R.^ORCID,Ardon Christine B.^ORCID,Prens Errol P.^ORCID,van der Zee Hessel H.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-021-01566-2.pdf

Reference100 articles.

1. Sabat R, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.

2. Jfri A, Nassim D, O'Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis. JAMA Dermatol. 2021. https://doi.org/10.1001/jamadermatol.2021.1677.

3. Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):990–8.

4. Matusiak L. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol. 2020;183(6):e171–7.

5. Vossen A, van der Zee HH, Prens EP. Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018;9:2965.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseases;JEADV Clinical Practice;2024-09

2. Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review;Frontiers in Medicine;2024-07-08

3. Targeted therapy for immune mediated skin diseases. What should a dermatologist know?;Anais Brasileiros de Dermatologia;2024-07

4. Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?;British Journal of Dermatology;2024-06-24

5. Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis;Heliyon;2024-06